VANGUARD GROUP INC - UNICYCIVE THERAPEUTICS INC ownership

UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 13 filers reported holding UNICYCIVE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of UNICYCIVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$98,949
-32.8%
115,0570.0%0.00%
Q2 2023$147,273
-39.0%
115,0570.0%0.00%
Q1 2023$241,620
+1871.6%
115,057
+407.0%
0.00%
Q4 2022$12,255
-5.7%
22,6950.0%0.00%
Q3 2022$13,000
-31.6%
22,6950.0%0.00%
Q2 2022$19,000
-34.5%
22,6950.0%0.00%
Q1 2022$29,000
-38.3%
22,6950.0%0.00%
Q4 2021$47,00022,6950.00%
Other shareholders
UNICYCIVE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Ayrton Capital LLC 76,645$158,0000.15%
Nantahala Capital Management 686,756$1,415,0000.05%
Board of Trustees of The Leland Stanford Junior University 247,583$510,0000.03%
TANDEM CAPITAL MANAGEMENT CORP /ADV 15,500$32,0000.02%
Frontier Wealth Management LLC 18,800$39,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 26,109$53,0000.00%
MORGAN STANLEY 2$00.00%
BlackRock Inc. 16,045$33,0000.00%
VANGUARD GROUP INC 22,695$47,0000.00%
View complete list of UNICYCIVE THERAPEUTICS INC shareholders